The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Vol.
36
No.
31
September 03, 2010Sep 03, 2010
DOWNLOAD THE PDF

Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal

Craig Thompson Of Abramson Center Named President, CEO, Of Memorial Sloan-Kettering

FDA Rejects Genentech Bid For Accelerated Approval For T-DM1. NCI Breaks Ground For Satellite Campus At Shady Grove

Committee To Set Research Agenda On Breast Cancer. Justice Department Appeals Injunction On Stem Cell Research

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account